Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Maria Kalyukina"'
Autor:
Xiaojing Lin, Yuliana Yosaatmadja, Maria Kalyukina, Martin J. Middleditch, Zhen Zhang, Xiaoyun Lu, Ke Ding, Adam V. Patterson, Jeff B. Smaill, Christopher J. Squire
Publikováno v:
ACS Med Chem Lett
[Image: see text] Aberration in FGFR4 signaling drives carcinogenesis and progression in a subset of hepatocellular carcinoma (HCC) patients, thereby making FGFR4 an attractive molecular target for this disease. Selective FGFR4 inhibition can be achi
Autor:
Adam V. Patterson, Yuliana Yosaatmadja, Martin Middleditch, Maria Kalyukina, Jeff B. Smaill, Christopher J. Squire
Publikováno v:
ChemMedChem. 14(4)
1-[(3S)-3-[4-Amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]-2-propen-1-one (TAS-120) is an irreversible inhibitor of the fibroblast growth factor receptor (FGFR) family, and is currently under phase I/II cl